Want to join the conversation?
$CIR lowered its 3Q16 sales outlook to $133-135MM from prior estimate of $140-150MM, and its adjusted EPS guidance to $0.41-0.45 from previous range of $0.45-0.55. $CIR now sees 3Q16 GAAP EPS of $0.22-0.28. CEO Scott Buckhout said preliminary results reflect prolonged weakness in Energy markets across both short and long cycle businesses.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?